The international journal of behavioral nutrition and physical activity

Experiences of workers and workplace leaders with a program to reduce sitting time at desks

Updated

Abstract

Workplace champions rated the training highly, with mean scores ranging from 5.3/6 to 5.7/6 across eight parts.

  • Most participants reported increased awareness of health consequences related to high levels of sitting, with 90.7% from the group and 88.2% from the SWAL plus desk group.
  • Motivation to change sitting time was noted by 77.5% of participants in the SWAL group and 85.77% in the SWAL plus desk group.
  • 70% of participants found the group catch-up sessions helpful, though responses varied regarding their effectiveness and other intervention components.
  • Participants using height-adjustable desks identified them as crucial for behavior change, influenced by intrinsic and time-related factors.
  • Reported benefits from the intervention included increased energy, reduced fatigue, improved focus, productivity, and fewer musculoskeletal problems in the SWAL plus desk group.
  • Barriers to reducing sitting time included work-related challenges, personal attributes, the physical office environment, and physical obstacles.

Simplified

Key numbers

5.3 to 5.7 out of 6
Training Session Rating
Mean scores from workplace champions on training session components.
90.7% ; 88.2% plus desk
Increased Awareness of Health Consequences
Participants' self-reported awareness of health consequences from the education component.
70%
Helpful Group Catch-Up Sessions
Percentage of participants who agreed the group sessions were helpful.

Full Text

What this is

  • The () intervention aimed to reduce sitting time in desk-based workers through various strategies.
  • Workplace champions were trained to facilitate the intervention, which included education, group sessions, and height-adjustable desks.
  • This paper focuses on the experiences of both the champions and participants regarding the intervention's effectiveness and challenges.

Essence

  • The intervention effectively reduced sitting time among desk-based workers, with feedback indicating positive experiences from both workplace champions and participants. However, responses varied, suggesting that different strategies may work better for different individuals.

Key takeaways

  • Workplace champions rated their training highly, with mean scores between 5.3/6 and 5.7/6, indicating effective preparation for their roles.
  • Participants reported that 90.7% in the group and 88.2% in the plus desk group felt more aware of the health consequences of sitting, motivating them to change their behavior.
  • Many participants (70%) found the group catch-up sessions helpful, although feedback was mixed regarding their effectiveness and engagement.

Caveats

  • The intervention's impact on reducing sitting time was primarily observed during work hours, with limited behavior change reported outside of work.
  • Variability in responses to intervention strategies suggests that a tailored approach may be necessary rather than a one-size-fits-all model.

Definitions

  • SMART Work & Life (SWAL): A multi-component intervention designed to reduce sitting time in desk-based workers through various strategies, including education and environmental changes.

Simplified

Funding

Competing interests

Authors declare support from the National Institute for Health and Care Research (NIHR) public health research programme, the Leicester Clinical Trials Unit, the NIHR Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre. MHG is a co-inventor of the activPAL3 physical activity monitor and a director of PAL Technologies. DWD reports grants from National Health and Medical Research Council (Australia), Diabetes Australia, and the National Heart Foundation of Australia, during the conduct of the study. GNH reports grants from the National Health and Medical Research Council (Australia) during the conduct of the study. MJD reports personal fees from Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp and Dohme, Boehringer Ingelheim, AstraZeneca, Janssen, Servier, Mitsubishi Tanabe Pharma, and Takeda Pharmaceuticals International, and grants from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, and Janssen outside the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free